Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcutis Biotherapeutics (ARQT) EPS (Basic): 2020-2024

Historic EPS (Basic) for Arcutis Biotherapeutics (ARQT) over the last 5 years, with Dec 2024 value amounting to -$1.16.

  • Arcutis Biotherapeutics' EPS (Basic) rose 118.18% to $0.06 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.35, marking a year-over-year increase of 78.92%. This contributed to the annual value of -$1.16 for FY2024, which is 69.31% up from last year.
  • As of FY2024, Arcutis Biotherapeutics' EPS (Basic) stood at -$1.16, which was up 69.31% from -$3.78 recorded in FY2023.
  • Arcutis Biotherapeutics' EPS (Basic)'s 5-year high stood at -$1.16 during FY2024, with a 5-year trough of -$5.66 in FY2022.
  • For the 3-year period, Arcutis Biotherapeutics' EPS (Basic) averaged around -$3.53, with its median value being -$3.78 (2023).
  • Per our database at Business Quant, Arcutis Biotherapeutics' EPS (Basic) plummeted by 35.41% in 2022 and then spiked by 69.31% in 2024.
  • Yearly analysis of 5 years shows Arcutis Biotherapeutics' EPS (Basic) stood at -$3.80 in 2020, then decreased by 10.00% to -$4.18 in 2021, then crashed by 35.41% to -$5.66 in 2022, then skyrocketed by 33.22% to -$3.78 in 2023, then surged by 69.31% to -$1.16 in 2024.